The management of obesity is rapidly evolving, with GLP-1 agonists offering new treatment options, and potentially more impressive therapies on the horizon.
This event will keep you at the cutting-edge of the latest research and practice in the field, and enable you to share insight with peers, to improve clinical outcomes.